Skip to main content

Table 2 Comparison between the higher BMI group and the lower BMI group

From: Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer

Characteristics

Higher BMI (n = 288)

Lower BMI (n = 286)

P value

Age (years)

68.6 ± 9.4

67.8 ± 9.7

0.334

Sex

  

0.682

  Male

171 (59.4%)

165 (57.7%)

 

  Female

117 (40.6%)

121 (42.3%)

 

Smoking

103 (35.8%)

102 (35.7%)

0.980

Drinking

89 (30.9%)

83 (29.0%)

0.443

Hypertension

188 (65.3%)

131 (45.8%)

< 0.01*

CHD

42 (14.6%)

16 (5.6%)

< 0.01*

Family history

12 (4.2%)

6 (2.1%)

0.155

Tumor location

  

0.933

  Rectum

144 (50.0%)

144 (50.3%)

 

  Colon

144 (50.0%)

142 (49.7%)

 

TNM stage

  

0.249

  I

56 (19.4%)

39 (13.6%)

 

  II

115 (39.9%)

118 (41.3%)

 

  III

97 (33.7%)

111 (38.8%)

 

  IV

20 (7.0%)

18 (6.3%)

 

Vessel invasion

12 (4.2%)

19 (6.6%)

0.189

Perineural invasion

10 (3.5%)

6 (2.1%)

0.317

Adjuvant therapy

19 (6.6%)

20 (7.0%)

0.851

Operation time (minutes)

232.8 ± 83.9

228.8 ± 85.6

0.577

Blood loss (mL)

105.6 ± 132.0

183.6 ± 10.9

0.568

Retrieved lymph nodes

14.3 ± 10.8

14.9 ± 7.0

0.439

Overall complications

73 (25.3%)

92 (32.2%)

0.071

Major complications

10 (3.5%)

9 (3.1%)

0.828

Hospital stay (days)

12.3 ± 11.9

12.8 ± 10.5

0.562

  1. Note: Variables are expressed as the mean ± SD, n (%), *P-value < 0.05
  2. Abbreviations: BMI Body mass index, CHD Coronary heart disease, TNM Tumor nodes metastasis